IL19 and familial pancreatic carcinoma: Immunofluorescence analysis confirmed the presence of IL-19 in the TME of clinical pancreatic cancer samples, which is consistent with findings in previous studies [18, 19], suggesting the mechanism by which TME factors promote the stemness of pancreatic cancer cells.